What is the appropriate first‑line antibiotic therapy for a child with mild crackles, low‑grade fever, and a productive cough who is otherwise well?

First-Line Antibiotic for Mild Community-Acquired Pneumonia in Children

Oral amoxicillin at 90 mg/kg/day divided into 2 doses is the first-line antibiotic for this child with mild crackles, low-grade fever, and productive cough. 1

Clinical Context

This presentation—mild crackles (creps), low-grade fever, productive cough in an otherwise well child—represents non-severe community-acquired pneumonia (CAP). The child does not require hospitalization based on the clinical description.

Dosing and Duration

• Amoxicillin: 90 mg/kg/day divided into 2 doses (or 45 mg/kg/day in 3 doses as alternative) 1
• Duration: 3-5 days is sufficient for uncomplicated cases 2, 3
• This high-dose regimen covers Streptococcus pneumoniae with intermediate penicillin resistance (MIC <2.0 µg/mL), which is the most common bacterial pathogen 1

Why Amoxicillin?

The 2011 PIDS/IDSA guidelines provide strong recommendation with high-quality evidence for amoxicillin as first-line therapy 4. This supersedes older WHO recommendations that included co-trimoxazole as an alternative, which now has a weak recommendation with only intermediate-quality evidence due to widespread resistance 4.

Key advantages:

• Excellent coverage of S. pneumoniae, the primary bacterial pathogen
• Covers Group A Streptococcus (50-75 mg/kg/day range) 1
• Superior to co-trimoxazole in areas with antimicrobial resistance 4
• Well-tolerated oral formulation
• Cost-effective

When to Consider Alternatives

Add a macrolide (azithromycin 10 mg/kg day 1, then 5 mg/kg days 2-5) if:

• Child is school-aged (≥5 years) where Mycoplasma pneumoniae becomes more likely 1
• Symptoms persist beyond 48-72 hours on amoxicillin alone
• Epidemiologic factors suggest atypical pathogens

Consider amoxicillin-clavulanate (90 mg/kg/day of amoxicillin component in 2 doses) if:

• Recent antibiotic exposure within past 3 months
• Concern for β-lactamase producing Haemophilus influenzae 1

Common Pitfalls to Avoid

1. Don't use cough suppressants for productive cough—the cough is protective and helps clear secretions
2. Don't prescribe antibiotics for viral pneumonia—but distinguishing bacterial from viral in real-world practice is challenging without point-of-care diagnostics 5
3. Don't underdose amoxicillin—the 90 mg/kg/day dose (not 45 mg/kg/day) is critical for pneumococcal coverage given current resistance patterns 1
4. Don't extend treatment beyond 5 days unless clinical deterioration occurs—longer courses increase antimicrobial resistance without improving outcomes 3

Monitoring for Treatment Failure

Reassess at 48-72 hours. Treatment failure indicators include:

• Persistent or worsening fever
• Increased work of breathing
• Decreased oral intake/dehydration
• New or worsening hypoxia
• Clinical deterioration

If treatment failure occurs, consider:

• Second-line oral therapy: Amoxicillin-clavulanate or add azithromycin 4
• Hospitalization if respiratory distress develops or child becomes toxic-appearing
• Parenteral therapy (ceftriaxone 50-100 mg/kg/day) for severe cases 1

Special Considerations

• Age matters: In infants <3 months, lower threshold for hospitalization and parenteral therapy 1, 6
• Immunization status: Fully immunized children have lower risk of invasive pneumococcal disease 1
• Local resistance patterns: In areas with high-level penicillin resistance (MIC ≥4.0 µg/mL), consider ceftriaxone, though this is uncommon in outpatient settings 1

The evidence strongly supports starting with oral amoxicillin for this clinical scenario, reserving broader-spectrum agents and parenteral therapy for treatment failures or more severe presentations 4, 1, 7, 2.